Jefferies Financial Group’s Halozyme HALO Stock Holding History

Jefferies Financial Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,500	Closed	-$1.45M	–	1937
2025 Q4	$1.45M	Buy	+21,500	New	+$1.45M	0.01%	932
2024 Q1	–	Sell	-74,200	Closed	-$2.74M	–	1776
2023 Q4	$2.74M	Buy	74,200 +25,400	+52%	+$957K	0.02%	592
2023 Q3	$1.86M	Sell	48,800 -49,200	-50%	-$2.02M	0.02%	645
2023 Q2	$3.53M	Buy	+98,000	New	+$3.34M	0.03%	470

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Jefferies Financial Group's HALO Position: Q2 2026 in Review

Jefferies Financial Group increased its Halozyme (HALO) stake by 44% in Q2 2026, buying an estimated $961K and bringing the position to 46,091 shares worth $3.61M. The position accounts for 0.02% of the portfolio, ranked #484.

Jefferies Financial Group first reported a position in HALO in Q2 2023 and has held it in 6 quarters since. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Jefferies Financial Group held 46,091 shares of Halozyme worth $3.61M as of Q2 2026.
Jefferies Financial Group bought 14,091 Halozyme shares in Q2 2026, an estimated $961K.
Halozyme made up 0.02% of Jefferies Financial Group's portfolio in Q2 2026, its #484 holding.
Jefferies Financial Group first reported a position in Halozyme in Q2 2023 and has held it in 6 quarters since.
673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.